The QualityStocks Daily Tuesday, August 7th, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (IFMK) +71.25%

QualityStocks (MPIR) +30.00%

MarketBeat (EKSO) +28.02%

The QualityStocks Daily Stock List

InterCloud Systems, Inc. (ICLD)

Hit and Run Candle Sticks, Microcapmillionaires, PennyStockProphet, Penny Pick Finders, INO.com Market Report, BUYINS.NET, GreatStockPix, Broad Street, StocksImpossible, OTCBB Journal, Stock Onion, Stock Tips Network, Buzz Stocks, Greenbackers, Jason Bond, RedChip, Wealthpire Inc., Street Insider, PennyPro, Promotion Stock Secrets, Marketbeat, Planet Penny Stocks, and Investing Futures reported previously on InterCloud Systems, Inc. (ICLD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

InterCloud Systems, Inc. is a top provider of cloud networking orchestration and automation solutions and services. The Company provides contemporary Information Technology (IT) and network solutions to the enterprise markets through cloud computing and professional services. InterCloud provides cloud services (SaaS, PaaS, and IaaS), professional consulting, data solutions, and maintenance services.

Established in 2006, InterCloud Systems is based in Shrewsbury, New Jersey. The Company has its Netlayer.io software platform.

InterCloud Systems’ mission is to enable carriers to hasten the installment of Virtualized Network and IT Services. The Company is a foremost provider of cloud networking orchestration and automation for Software Defined Networking (SDN) and Network Function Virtualization (NFV) cloud environments. It is a provider to the telecommunications service provider (carrier) and corporate enterprise markets.

Regarding its Professional Services, InterCloud Systems has a 24×7 practice for many technologies. These include Unix/Linux System Administration; Microsoft System Administration; VMware Administration; and  Open Stack/Cloud Stack. In addition, these include Juniper Design, Operate & Support;  Cisco Design, Operate & Support; and Citrix Design, Operate & Support.

The Company’s cloud solutions provide enterprise and service-provider customers the opportunity to adopt an operational expense model via outsourcing cloud deployment and management to InterCloud Systems.

InterCloud’s products and solutions include NFVGrid – NFVO Management & Analytics Platform. This is a full-scale next generation networking platform for virtualized network functions. NFVGrid is proprietary IP. However, NFVGrid completely embraces Open Source.

The Company’s solutions include Disaster Recovery. Its cloud backup permits one to backup their vital business data to a remote and secure location for speedy disaster recovery.

InterCloud Systems announced this past March the Closing on the sale of ADEX Corporation.  Under the terms of the asset sale, the Company will receive $5 Million in a combination of cash and seller’s note.

Last month, InterCloud Systems announced that it was recently awarded more than $510,000.00 in new contracts for Next-Gen Wi-Fi and DAS services for new and existing customers. The expectation is that a majority of the work will start over the summer and fall.

The Company also announced in July that it was recently awarded more than $700,000.00 in new contracts for Next-Gen WiFi and DAS systems to be performed over Q3 and Q4 2018.

Mr. Mark Munro, InterCloud Systems’ Chief Executive Officer, stated “We continue to sign new business for our remaining business units. We continue to streamline costs and eliminate senior and sub debt. Our SD-WAN group is diligently working with our recently announced client to move to a production environment from the testing platform. This will be an important milestone for both parties.”  

InterCloud Systems, Inc. (ICLD), closed Tuesday's trading session at $0.014, down 12.50%, on 2,317,772 volume with 78 trades. The average volume for the last 60 days is 2,272,774 and the stock's 52-week low/high is $0.012/$2.12.

chart

AdvanSource Biomaterials Corp. (ASNB)

TopPennyStockMovers, Zacks, Money Morning, S.A. Advisory, Marketbeat, Penny Stock Tweets, and Nebula Stocks reported on AdvanSource Biomaterials Corp. (ASNB), and we also report on the Company, here at the QualityStocks Daily Newsletter.

AdvanSource Biomaterials Corp. is an ISO certified materials technology company headquartered in Wilmington, Massachusetts. Specialists in polyurethane technologies, the Company provides a variety of material formats for use in long and short-term implants and disposable products. Fundamentally, AdvanSource is a foremost developer of advanced polymer materials for a wide spectrum of medical devices.

AdvanSource Biomaterials lists on the OTC Markets’ OTCQB. The Company formerly went by the name CardioTech International, Inc. It changed its name to AdvanSource Biomaterials Corp. in October of 2008.

The Company serves the medical device and pharmaceutical market. AdvanSource’s materials have a history of use in short and long-term implant applications. These include stents, artificial heart valves, VADs, catheters, guidewires, and introducers.

AdvanSource Biomaterials’ expertise lies in the synthesis and formulation of polymeric materials with a broad array of physical and chemical properties. These materials possess innovative characteristics including biocompatibility and biodurability. They can be tailored for specific properties, including lubricity and antimicrobial formats.

The Company’s biomaterials are used in devices designed for treating a wide spectrum of anatomical sites and disease states. Products include ChronoFlex AL; ChronoFlex AR; ChronoFlex C; ChronoPrene; ChronoSil; ChronoThane P; ChronoThane T; HydroMed; HydroThane; and PolyBlend.

ChronoFlex AL is a family of biodurable aliphatic polycarbonate-based thermoplastic urethanes. The design of these is to overcome surface degradation such as stress-induced microfissures.

PolyBlend is a family of very soft, aromatic polyurethane elastomeric alloys. These can be used as a substitute for natural rubber or latex in many applications. HydroMed is a series of ether-based hydrophilic urethanes with premier adhesive and cohesive properties.

Markets AdvanSource Biomaterials serves include orthopedics, cardiovascular, drug delivery, endoscopy, neurology, urology, spine, interventional radiology, peripheral vascular, ENT, gastroenterology, oncology, and diabetes management.

The Company has a strategic alliance with Medibrane Ltd. Medibrane is a top Israeli coating technology company. The Strategic Alliance provides for technology collaboration, development, and commercialization of medical coatings utilizing AdvanSource’s material technologies in collaboration with Medibrane’s coating and surface modification technologies and enhancements. Medibrane is a designer, developer and manufacturer of customized polymeric surgical implants, implantable device coatings, encapsulation coatings, as well as bio-absorbable implants.

AdvanSource Biomaterials Corp. (ASNB), closed Tuesday's trading session at $0.06524, up 12.29%, on 1,693 volume with 2 trades. The average volume for the last 60 days is 58,552 and the stock's 52-week low/high is $0.0281/$0.10.

chart

The Alkaline Water Company, Inc. (WTER)

StreetAuthority Financial, Dynamic Wealth Research, Investor Spec Sheet, Market FN, Wall Street Mover, Morningstar, SmallCapVoice, OTC Markets Group, Penny Stock Rumble, InvestmentHouse, Investors Insights, MicroCap Gems, Oakshire News Bulletin, and The Best Newsletters reported on The Alkaline Water Company, Inc. (WTER), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Alkaline Water Company, Inc. has developed a unique, state-of-the-art, proprietary electrolysis beverage process. This process produces healthy alkaline water. The water is packaged and sold in 500ml, 700ml, 1-liter, 3-liter and 1-gallon sizes under the trade name Alkaline88®. Alkaline88's premier alkaline water is a pH balanced bottled alkaline drinking water enhanced with trace minerals and electrolytes.

The Alkaline Water Company has its corporate office in Scottsdale, Arizona. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Alkaline Water Company currently packages and sells its alkaline water to greater than 40,000 retail locations in all 50 states. The design of Alkaline88 is to encourage daily consumption of Alkaline Water by way of a consumer-oriented bulk delivery system aimed at removing expensive small bottles from the distribution supply chain. The production of Alkaline88 is at an 8.8 pH, intended to attain optimal body balance.

The Company incorporated 84 beneficial trace Himalayan minerals to make Alkaline88 especially unique to other pH waters. It utilizes an advanced Electrochemically Activated Water (ECA) system to create 8.8 pH drinking water without the use of any chemicals.

The ECA process uses specialized electronic cells coated with an array of rare earth minerals to produce scientifically engineered water. Alkaline88® is now available at select retailers in a 1.5-liter bottle and a 1-liter 6-pack.

Recently, The Alkaline Water Company announced record quarterly Sales were realized in its Q1 for the fiscal year ending March 31, 2019. The Company had record Q1 FY 2019 Sales of more than $7.85 million. Q1 FY 2019 Sales of more than $7.85 million were up over 51 percent versus Q1 FY 2018 Sales of $5.17 million.

The Alkaline Water Company also recently announced that its Phoenix, Arizona based co-packer, White Water, expanded its manufacturing facility that will substantially increase wholesale production capacity. At present, White Water occupies a 62,000 square foot facility, which operates six bottling lines with close to 50 employees. White Water is one of the largest privately-owned bottled water companies in the Southwest.

The Alkaline Water Company announced in late July that Heinen’s Inc., d/b/a Heinen’s Grocery Store (Cleveland, Ohio based) is now selling Alkaline88® water in its 1-gallon size at all of their retail locations throughout Ohio and Illinois.   

The Alkaline Water Company, Inc. (WTER), closed Tuesday's trading session at $1.92, down 2.54%, on 25,928 volume with 45 trades. The average volume for the last 60 days is 52,780 and the stock's 52-week low/high is $0.80/$2.25.

chart

Sun BioPharma, Inc. (SNBP)

AheadoftheBulls.com, AllPennyStocks, TheStockWizards.net, The Dean, FeedBlitz, MicrocapVoice, Today's Financial News, HotPennyStocksNow, OTC Picks, Hot Shot Stocks, Wall Street Resources, Beacon Equity Research, Greenbackers, CoolPennyStocks, Otcstockexchange, HotOTC, and Lebed.biz reported previously on Sun BioPharma, Inc. (SNBP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Sun BioPharma, Inc. is a biopharmaceutical company listed on the OTC Markets Group’s OTCQB. The Company is developing disruptive therapeutics for the treatment of patients with pancreatic diseases. A clinical-stage biopharmaceutical company, Sun BioPharma’s development programs target diseases of the pancreas. This includes pancreatic cancer and pancreatitis. Sun BioPharma has its corporate headquarters in Waconia, Minnesota.

The Company’s initial product candidate is SBP-101. This product is for the treatment of patients with pancreatic cancer. Mr. Ray Bergeron, Ph.D. Distinguished Professor Emeritus, University of Florida invented SBP-101. Sun BioPharma’s plan is to develop SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma, which is the most common kind of pancreatic cancer.

SBP-101 is a first-in-class, proprietary, polyamine compound. The design of it is to exert therapeutic effects in a mechanism specific to the pancreas. The Company originally licensed SBP-101 from the University of Florida in 2011.

The molecule has been demonstrated to be highly effective in human pancreatic cancer models. It has shown superior activity to existing Food and Drug Administration (FDA) approved chemotherapy agents. Additionally, combination therapy potential has been demonstrated for pancreatic cancer.

In addition, Sun BioPharma’s SBP-102 is presently in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. As well, Sun BioPharma’s SBP-103 is currently in non-clinical exploratory evaluation.

Sun BioPharma has scientific collaborations with pancreatic disease experts at Cedars Sinai Medical Center in Los Angeles, California; the University of Miami; the University of Florida; the Mayo Clinic Scottsdale; the Austin Health Cancer Trials Centre and the Box Hill Hospital in Melbourne, Australia, and the Ashford Cancer Centre in Adelaide, Australia.

Sun BioPharma announced in October 2017 the successful completion of patient enrolment in its Phase 1a dose escalation safety study using SBP-101 for patients with previously treated locally advanced or metastatic pancreatic ductal adenocarcinoma (PDA). Upon reviewing data from the sixth and final cohort of patients, and data from all 29 patients enrolled in the study, the Data Safety Monitoring Board (DSMB) recommended a safe and well-tolerated dose level of SBP-101 to be used for more clinical development.

In late January, Sun BioPharma announced its initiation of a first-line dose-escalation study of SBP-101 in combination with gemcitabine and nab-paclitaxel in previously untreated patients with metastatic pancreatic cancer. The anticipation is that the first patient will be enrolled in early Q2 2018.

The expectation is that clinical sites participating in the study will include the University of Florida, in Gainesville, Florida, the Ashford Cancer Centre in Adelaide, the Olivia Newton-John Cancer and Wellness Centre in Melbourne and the Blacktown Cancer and Haematology Centre in Sydney, Australia.

Furthermore, Sun BioPharma announced the completion of the first-in-human safety study of SBP-101 in previously treated patients with pancreatic ductal adenocarcinoma (PDA). SBP-101 was well tolerated. Moreover, signals of efficacy were observed at dose levels below the Maximum Tolerated Dose (MTD).

Sun BioPharma, Inc. (SNBP), closed Tuesday's trading session at $4.60, up 1.10%, on 1,100 volume with 3 trades. The average volume for the last 60 days is 744 and the stock's 52-week low/high is $1.00/$20.90.

chart

Noble Roman's, Inc. (NROM)

FeedBlitz, The Bowser Report, StockOodles, Wall Street Resources, TaglichBrothers, Marketbeat.com, and SmallCapVoice reported earlier on Noble Roman's, Inc. (NROM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. Its business model consists of three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising.

The Company franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub (CPP)  trade names. Listed on the OTCQB, Noble Roman’s has its corporate headquarters in Indianapolis, Indiana.

Noble Roman’s Craft Pizza & Pub (CPP) features two styles of hand-crafted, made-from-scratch pizzas with a selection of 40 different toppings, cheeses, and sauces. In addition, beer and wine is featured, with 16 different beers on tap.

The Company has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. Additionally, it has awarded franchise and/or license agreements in Canada, Puerto Rico, the Bahamas, Italy, and the Dominican Republic.

Grocery Take-n-Bake Licensing involves licensing of individual Groceries to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

Pertaining to Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the kinds of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Regarding Non-Traditional Venues, these are usually located in a host facility whose principal business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit. Example kinds of locations include Bowling Centers; Convenience Stores; Walmart®/Retail Centers; Hospitals; Entertainment Facilities; as well as Military Bases.

Last month, Noble Roman's announced that the third of its new-generation, stand-alone pizzerias (Noble Roman's Craft Pizza & Pub (CPP)) has also surpassed its opening 7-day sales target. Opening on January 18, 2018, the first seven-day total sales volume was $36,605, closely in line with the previous two locations. Noble Roman's newest CPP location is in Fishers, Indiana on Allisonville Road just north of 116th Street.

The first Noble Roman's CPP opened on January 31, 2017 in Westfield, Indiana in the Monon Marketplace on Main Street/Highway 32 across from Grand Park. The second CPP opened on November 17, 2017 in Whitestown, Indiana, just off I65 in Anson Village. The fourth Company-owned and operated CPP is on rack to open this spring.

Noble Roman's, Inc. (NROM), closed Tuesday's trading session at $0.66, up 4.76%, on 3,600 volume with 4 trades. The average volume for the last 60 days is 20,888 and the stock's 52-week low/high is $0.38/$0.87.

chart

Maricann Group, Inc. (MRRCF)

Weed Newswire, Stockhouse, Investopedia, Insider Financial, YCharts, The Street, MarketWatch, 4-Traders, OTC Markets, Barchart, NewCannabisVentures, Marketwired, Investors Hub, and TradingView reported on Maricann Group, Inc. (MRRCF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Maricann Group, Inc. produces and distributes marijuana for medical purposes. The Company offers dried marijuana, cannabis oil, as well as gums. Moreover, it provides accessories. This includes vaporizers, grinders, and other paraphernalia. Maricann Group is based in Burlington, Ontario, and Munich, Germany. It has production facilities in Langton, Ontario.

The Company is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Maricann Group has federal licenses in Canada to cultivate, extract, formulate, and distribute cannabis.

Its Germany-based Ebersbach facility targets the considerable European market with 820,000 sq. ft. of cultivation space and more than 12,000 patients. Maricann has developed educational programming for patients and healthcare professionals. Via exclusive pharmacy agreements with about 20 percent of the nation’s pharmacies, Maricann is working to become a foremost provider of cannabis at physical point-of-sale locations that patients trust.

In Langton, Ontario, Maricann operates a medicinal cannabis cultivation, extraction, and formulation and distribution business under federal license from the Government of Canada, and Dresden, Saxony, Germany.

Maricann’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. Currently, the Company is undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, to support existing and future patient growth.

One of Maricann Group’s acquisition’s is NanoLeaf Technologies. NanoLeaf is a biotechnology company that has licensing rights to several internationally patented technologies, which provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.

Maricann Group has also completed the acquisition of all outstanding shares of Haxxon AG. This acquisition of Haxxon forms a vital element of Maricann’s European expansion strategy. Maricann is now positioned to enter the Swiss market by way of Haxxon’s production of feminized high CBD cannabis plants.

Last month, Maricann Group announced that it was chosen by the BC Liquor Distribution Branch (BCLDB) to enter into a Memorandum of Understanding (MOU) as a preferred licensed producer to initially supply roughly 3,621,900g (approximately 3,622kg) of non-medical cannabis to BCLDB over the first 12 months after legalization. Maricann now has confirmed recreational cannabis allocations for Manitoba, Alberta, and British Columbia totaling an annualized volume of 10,923,100g (approximately 10,923kg).

Also in July, Maricann announced that Malta Enterprise approved the Company's application to set up a business in Malta to manufacture finished dose medical cannabis. The license permits Maricann to supply its Maltese operation with raw materials that will subsequently undergo advanced post processing to create pure cannabis distillates, allowing for true pharmaceutical manufacturing. Malta Enterprise is the nation's official economic development agency and the government entity responsible for licenses.

Maricann Group, Inc. (MRRCF), closed Tuesday's trading session at $1.169976, up 5.40%, on 152,647 volume with 96 trades. The average volume for the last 60 days is 64,773 and the stock's 52-week low/high is $0.8698/$3.60.

chart

Cell Source, Inc. (CLCS)

InvestorsHub and OTC Markets reported on Cell Source, Inc. (CLCS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Cell Source, Inc. is a Biotechnology Company listed on the OTC Markets Group’s OTCQB. The Company concentrates on developing cell therapy treatments established on immunotherapy and regenerative medicine. Its principal product is the Veto-Cell immune system management technology. Cell Source has its headquarters in New York, New York.

Cell Source’s Veto-Cell immune system management technology is an immune tolerance biotechnology. It enables the selective blocking of immune responses. The Company’s Veto-Cell technology is utilized in varied applications. These include bone marrow transplantation, veto-cell in transplantation, anti-cancer, and also non-malignant diseases.

The patented Veto-Cell technology addresses one of the most fundamental challenges in human immunology. This challenge is: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats.

Veto cells disable the attack of the immune system on the bone marrow transplantation (BMT) only, without other side effects. The Veto cells act as “decoys” that attract, and then kill, the T-cell clones directed at the transplant.

The Veto cells continue “on guard” in the body for lengthy periods of time to further limit rejection. Therefore, the transplantation is accepted by the body without compromising the rest of the immune system.

The principal goal in developing Veto Cells is to have a meaningful and potentially widespread impact on the field of bone marrow and major organ transplantation. In addition, Veto Cells can be combined with other cell therapy treatments to improve their effectiveness. In preclinical studies, Veto Cells have been shown to increase efficacy and persistence of genetically modified cells.

Along with its Veto Cells technology, Cell Source has its Megadose Drug Combination technology. The method of action includes stem cells overcoming rejection by outnumbering immune rejecting cells, and drugs reduce the need for immune suppression.

The Company has a substantial Intellectual Property (IP) Portfolio, exclusively licensed to it from the Weizmann Institute of Science by way of Yeda Research and Development Company Ltd. covering Dr. Yair Reisner’s technologies.

Dr. Yair Reisner is former Chairman of the Department of Immunology of Israel’s Weizmann Institute of Science. He pioneered “mismatched” BMT (partial versus full donor/recipient match) with his patented “Megadose” cell therapy treatment.

In essence, Cell Source’s corporate mission is to transform the fields of transplantation, cancer treatment, and reversal of vital organ disease, using its pioneering immune tolerance and organ regeneration technologies.

Cell Source, Inc. (CLCS), closed Tuesday's trading session at $0.79, up 16.18%, on 200 volume with 2 trades. The average volume for the last 60 days is 1,842 and the stock's 52-week low/high is $0.1502/$0.849.

chart

ReelTime Rentals, Inc. (RLTR)

Penny Stock Tweets, 4-Traders, MarketWatch, Stockhouse, Marketwired, WalletInvestor, Penny Stock Hub, Barchart, Simply Wall St, InvestorsHub, and OTC Markets reported on ReelTime Rentals, Inc. (RLTR), and we also report on the Company, here at the QualityStocks Daily Newsletter.

ReelTime Rentals, Inc. (d/b/a ReelTime VR, ReelTime Media Group) is a multimedia publishing company. It engages in helping individuals that have been thrust into the public eye to monetize their exposure and control the portrayal of their story. ReelTime is based in Seattle, Washington.

The Company also develops, produces, and distributes Virtual Reality (VR) Content and technologies under the brand ReelTime VR. It has end to end production, editing, as well as distribution capabilities for internal and external projects.

Currently, ReelTime produces three ongoing series for the Samsung Gear VR platform, VeeR TV, Oculus. It distributes them over numerous VR delivery sites.

Concerning VR Set Design, ReelTime has a totally-dressed virtual set in its studio facilities. It can create any look one wants for their Virtual Reality show. Moreover, it can provide traditional virtual set backdrops.

Regarding VR Content Production, ReelTime has a team of editors and other pre/post-production professionals available for all aspects of producing VR content. This is from the initial design concepts, to pixel-perfect deliverables.

Pertaining to Partnerships, ReelTime partners with other leading VR distributors, content producers, and technology providers. Additionally, regarding its Services, the Company offers Consulting, Production, Monetization, VR Set Design, VR Media Campaigns, and VR Content Production.

This past June, ReelTime VR announced that it received patent-pending status from the United States Patent and Trademark Office (USPTO) for its non-provisional patent application encompassing apparatus and method claims for technology involving simultaneous capturing of 360 X 360-degree Spherical Panorama Images and Video. The technology will permit any cell phone or other camera to instantaneously capture 360 X 360 Virtual Reality Video or pictures without any necessity for stitching.

Recently, ReelTime VR announced that it became the first to employ a proprietary technology developed by the Company, which allows it to film in full 360 x 360 Virtual Reality formats and at the same time film in formats compatible with traditional Television platforms. This will allow ReelTime VRs shows the Company produces to not only be available on the fast-growing premium VR sites it is now available on, but it will additionally be available for distribution over mainstream Network Television formats and globally.

ReelTime Rentals, Inc. (RLTR), closed Tuesday's trading session at $0.023, up 4.55%, on 92,889 volume with 7 trades. The average volume for the last 60 days is 92,037 and the stock's 52-week low/high is $0.001/$0.08.

chart

Empire Diversified Energy, Inc. (MPIR)

MarketWatch, OTC Markets, InvestorsHub, Morningstar, Investing.com, Stockhouse, Stockopedia, YCharts, Investors Hangout, PennyStockHub, EquityNet.com, OtcDynamics.com, Penny Stock Tweets, DividendInvestor.com, Biz Journals, and Hot Penny Stocks reported on Empire Diversified Energy, Inc. (MPIR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Fort Lauderdale, Florida based, Empire Diversified Energy, Inc.’s main mission is to serve the challenges of the energy Industry with inventive solutions chiefly related to the safe removal and disposal of Coal Combustion Residue (CCR), usually referred to as coal ash, from the nation’s utilities storage ponds. Fundamentally, the Company’s mission is to help clean up the existing environment and develop clean fuel sources in the future. Empire Diversified Energy lists on the OTC Markets Group’s OTCQB.

Empire Diversified Energy specializes in Diversified Green Energy projects. It is a full-service business. It offers strategic consulting and unique environmental solutions to address industry issues including the aforementioned CCR remediation and renewable energy alternatives. The Company has identified a niche market opportunity in the fly ash remediation sector.

At present, Empire Diversified Energy is initiating coal-reduction strategies involving increased use of sustainable biomass. Moreover, the Company’s longer-term plans will be to diversify into zero-emission fuel science and the extensive use of economically-viable hydro-electric, solar, as well as wind technologies.

Empire Diversified Energy plans to acquire certain assets. These include, but are not limited to, logistical equipment, coal mines, landfills, solar equipment and biomass inventories. This is because it is working to implement a vertical integration strategy.

The Company acquired DTE Dickerson, LLC. It completed its acquisition on the DTE Dickerson property in May of 2017. Assets in the Dickerson included all coal, coal slurry, coal waste and coal refuse situated within the property; a surety bond in the amount of $1,203,500; a slurry disposal area; prep plant; and varied permits.

The Dickerson Property has coal refuse and coal waste that can be removed and blended at other close by established coal mines. The Dickerson Property is situated within a 20-mile radius of a number of established mining complexes that will allow DTE Dickerson to customize blends of coal.

Presently, Empire Diversified Energy is developing a hybrid alternative fuel pellet (HAFP). It is intended to permit utilities and other enterprises, which currently burn solid and gaseous fuel sources to transition from these traditional sources to HAFP’s.

In addition, the Company is developing its own proprietary binding agent. It will be filed with the appropriate international patent agencies to become patent protected. This binding agent will allow HAFP’s to be employed across a more extensive range of platforms. This will allow Empire Diversified Energy to introduce its HAFP’s to older utilities, cement manufacturers, aluminum and steel manufacturers.

Empire Diversified Energy, Inc. (MPIR), closed Tuesday's trading session at $1.30, up 30.00%, on 100 volume with 1 trade. The average volume for the last 60 days is 135 and the stock's 52-week low/high is $0.312/$5.00.

chart

Rezolute, Inc. (RZLT)

Penny Stock Tweets, Zacks, YCharts, Investors Hangout, InvestorsHub MarketWatch, The Street, Stockhouse, Barchart, OTC Markets, 4-Traders, WeeklyHub.com, Amigo Bulls, Equities.com, and Dividend Investor reported on Rezolute, Inc. (RZLT), and today we are highlighting the Company, here at the Quality Stocks Daily Newsletter.

Based in Louisville, Colorado, Rezolute, Inc. is a clinical stage biopharmaceutical company. It specializes in the development of unique drug therapies for metabolic and orphan diseases. The Company previously went by the name AntriaBio, Inc. It changed its name to Rezolute, Inc. in December of 2017. Rezolute’s shares trade on the OTC Markets Group’s OTCQB.

The Company is advancing a varied pipeline. This pipeline includes RZ358 (Phase 2), an antibody for the ultra-orphan indication of Congenital HyperInsulinism (CHI), with an abbreviated path-to-market strategy. The pipeline also includes AB101 (Phase 1). This is a once-weekly injectable basal insulin with the potential to transform the treatment landscape in diabetes management through lessening the therapeutic burden for patients and improving compliance.

Rezolute’s pipeline also includes a Plasma Kallikrein Inhibitor (PKI) portfolio with two lead compounds, RZ402 targeting Diabetic Macular Edema (DME) and RZ602 targeting Hereditary Angioedema (HAE), an orphan indication.

In early December 2017, Rezolute and XOMA Corporation announced that they executed a license agreement. This agreement provides Rezolute with the exclusive worldwide rights to develop and commercialize RZ358 (previously XOMA 358) for Congenital Hyperinsulinism (CHI), an ultra-orphan indication. XOMA is a pioneer in the discovery, development, and licensing of therapeutic antibodies.

RZ358 is a first-in-class fully human monoclonal antibody. It counteracts the effects of elevated insulin by way of allosteric modulation of the insulin receptor. This makes it well-suited as a therapy for severe, persistent hypoglycemia caused by hyperinsulinemic conditions such as CHI.

Recently, Rezolute announced that it entered into a common stock purchase agreement with Lincoln Park Capital Fund, LLC (LPC). LPC is a Chicago-based institutional investor. LPC manages a portfolio of investments in public and private entities.

After the Securities and Exchange Commission (SEC) declares an effective registration statement regarding the transaction, Rezolute will have the right and sole discretion to sell up to $10 million worth of shares to LPC over a 36-month period, subject to certain limitations.

Rezolute will control the timing and amount of any future investment. LPC will be obligated to make purchases in accordance with the Agreement. Proceeds from the Agreement will be used for operations. They will also be used to advance the development of Rezolute’s product candidates and product collaborations.

Rezolute, Inc. (RZLT), closed Tuesday's trading session at $0.40, up 14.29%, on 7,550 volume with 3 trades. The average volume for the last 60 days is 8,461 and the stock's 52-week low/high is $0.35/$0.99.

chart

Kona Gold Solutions, Inc. (KGKG)

InvestorsHub, MarketWatch, OTC Markets, Barchart, 4-Traders, Investors Hangout. Information Vine, Penny Stock Tweets, The Street, Business Insider, SmallCapVoice, Simply Wall St, SmallCapExclusive.com, Stockopedia, Insider Financial, YCharts, Stockwatch, Dividend Investor, EmergingGrowth.com, MicroCapDaily, and PinkInvesting reported on Kona Gold Solutions, Inc. (KGKG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Kona Gold Solutions, Inc. is a hemp lifestyle brand centered on product development in the functional beverage sector. The Company has developed a premium Hemp Infused Energy Drink line, Energy shots, and Apparel. Kona Gold is a member of the Hemp Industries Association (HIA).

At the beginning of February, Kona Gold Solutions announced it will be moving its corporate headquarters to Melbourne, Florida.  Kona Gold signed a five-year lease at 746 North Drive, Suite A, Melbourne, Florida.

The new location will provide Kona with 4,500 square feet of office and warehouse space. This will allow accommodations for personnel growth and product expansion for wholly-owned subsidiaries Kona Gold, LLC; HighDrate, LLC; and BitHive Mining, LLC.  Kona’s move in date is scheduled for June 1, 2018.

The Company’s HighDrate subsidiary has developed the beverage industry’s first CBD Energy Water. It is available in four flavors – Watermelon, Kiwi Strawberry, Tropical Coconut, and Georgia Peach.

This subsidiary’s emphasis is on consumers that lead an active lifestyle and require a balanced beverage that will meet their needs of providing their mind and body with a focused boost and fast recovery.

In early January of this year, Kona Gold Solutions announced its strategy to diversify by creating a new, wholly-owned technology centered subsidiary,  the above-mentioned Bithive Mining, LLC. This subsidiary is to aggressively pursue cryptocurrency mining of Bitcoin and other cryptocurrencies. BitHive Mining will be exclusively centered on mining cryptocurrencies by way of custom built mining hardware. 

Bithive Mining will have dedicated personnel. Furthermore, the new initiative will have no impact on Kona Gold Solution’s main business in the functional beverage sector. The Company will bring its initial cryptocurrency mining rigs online in Q1 2018. They will operate on a 24/7 basis.

Mr. Robert Clark, Kona Gold Solutions’ Chief Executive Officer, said last month, “The world is currently witnessing two explosive markets taking place in the hemp and cryptocurrency industries and we are excited to announce the company will be a player in both. I have been involved in cryptocurrency since 2011, the early days of Bitcoin, and after discussing with our team and advisors, we have made the strategic decision to create a subsidiary solely dedicated to cryptocurrency mining on a 24/7 basis.”

Kona Gold Solutions, Inc. (KGKG), closed Tuesday's trading session at $0.0122, down 2.40%, on 218,750 volume with 11 trades. The average volume for the last 60 days is 1,227,241 and the stock's 52-week low/high is $0.005/$0.0338.

chart

Prophecy Development Corp. (PRPCF)

Stockhouse, Wallmine, GuruFocus, Wallet Investor, Junior Mining Network, OTC Markets, The StreetWise Reports, Barchart, 4-Traders, InvestorsHub, Business Wire, InvestorIntel, Marketwired, Uptick Newswire, and TradingView reported on Prophecy Development Corp. (PRPCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Prophecy Development Corp. engages in the acquisition, exploration, and development of mineral and energy projects. Its main goal is to develop the Gibellini primary vanadium mining project in the Battle Mountain area in northeastern Nevada to production. The Company previously went by the name Prophecy Coal Corp. It changed its corporate name to Prophecy Development Corp. in January of 2015.

Prophecy Development lists on the OTC Markets Group’s OTCQX. The Company is headquartered in Vancouver, British Columbia.

This past June, Prophecy Development announced the filing of a technical report prepared in accordance with National Instrument 43-101, Standards of Disclosure for Mineral Projects (NI 43-101) pertaining to a Preliminary Economic Assessment (PEA) for the Company’s Gibellini vanadium project in Eureka, Nevada. The project is approximately 25 miles south of the town of Eureka.

The design of the Gibellini vanadium project is to be an open pit, heap leach operation in Nevada’s Battle Mountain region. The PEA reported an after-tax cumulative cash flow of $601.5 million, an Internal Rate of Return (IRR) of 50.8 percent, a Net Present Value (NPV) of $338.3 million at a 7 percent discount rate and a 1.72 years payback on investment from start-up assuming an average vanadium pentoxide price (V2O5) of $12.73 per pound.

Prophecy Development also has its Pulacayo (Silver-Zinc-Lead) project. This Project is in Bolivia, 107 km northeast of Sumitomo Corporation’s San Cristobal silver mine; 185 km southwest of Coeur Mining, Inc.’s San Bartolome silver mine; and 139 km north of Pan American Silver Corp.’s San Vicente silver mine.

In addition, Prophecy has its Titan (Titanium Vanadium) Project. This Project is at Flett and Angus Townships, 120 kilometers northeast of Sudbury, Ontario. The Property comprises 262 contiguous hectares consisting of 17 patented claims.

In July, Prophecy Development announced that it is engaged in discussions with advisors concerning spinning off a vanadium royalty and streaming company (VRC). It would be a way to provide investors with direct participation in vanadium mining royalties, streaming, as well as physical vanadium.

Under the proposed structure, the Company would incorporate VRC as a wholly-owned subsidiary (subject to regulatory, shareholder, and other compulsory approvals). VCR would receive a minority portion of the vanadium production by Prophecy's Gibellini project in Nevada. The project would have the target of commencing production in 2021.

In exchange for the discounted vanadium purchase price, VRC would make a cash prepayment to Prophecy Development. This would cover the capital cost of building the Gibellini project, before Prophecy receiving all the permits needed to begin the Gibellini mine construction.

Prophecy Development Corp. (PRPCF), closed Tuesday's trading session at $1.6853, down 13.57%, on 17,804 volume with 25 trades. The average volume for the last 60 days is 8,042 and the stock's 52-week low/high is $1.2443/$4.00.

chart

The QualityStocks Company Corner

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF).

ABcann Global Corporation (TSX-V: ABCN, OTCQB: ABCCF) (“ABcann,” “VIVO” or the “Company”) is excited to announce that, effective immediately, it will be known as VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) — a contemporary reflection of the Company’s evolution, purpose and direction. The name change will be effective at market open on Tuesday, August 7, 2018 and “VIVO” will replace “ABCN” as the Company’s ticker symbol on the TSX Venture Exchange.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (ABCCF), closed the day's trading session at $1.1501, up 15.01%, on 431,592 volume with 346 trades. The average volume for the last 60 days is 208,371 and the stock's 52-week low/high is $0.65/$3.2929.

Recent News

chart

GreenBox POS, LLC (OTCQB: GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

GreenBox POS, LLC (OTCQB: GRBX), a payment and blockchain solutions entity, recently announced that it has accepted an invitation to appear in a special TV production set for broadcast on Fox Business Network in the September-October timeframe.

GreenBox POS, LLC (OTCQB: GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $1.55, up 23.26%, on 48,659 volume with 51 trades. The average volume for the last 60 days is 42,684 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

Zenergy Brands, Inc. (OTC: ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands, Inc. (OTC: ZNGY) is disrupting the energy industry by focusing on its Zero Cost Program™ and applying smart energy controls to reduce energy consumption from utilities and achieve lower upfront costs. It has signed a seven-year Managed Energy Services Agreement (MESA) worth $393,969 with a franchisee of a fast food chain for eight of its units. ZNGY is also in discussions with three more franchisees (http://nnw.fm/eHYP3).

Zenergy Brands, Inc. (OTC: ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0007, up 16.67%, on 9,655,677 volume with 28 trades. The average volume for the last 60 days is 21,133,298 and the stock's 52-week low/high is $0.005/$0.03.

Recent News

chart

BLOCKStrain Technology Corp. (TSX-V: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

Canada’s inexorable march toward full legalization of cannabis for the adult user in both the medical and recreational markets is much anticipated by the public and Vancouver, Canada-based BLOCKStrain Technology Corp. (TSX.V: DNAX). Major features of BLOCKStrain’s proprietary, end-to-end cannabis tracking platform are rapidly being finalized by the company’s development team, Chief Technology Officer Tommy Stephenson said in a news release (http://nnw.fm/Ud566).

BLOCKStrain Technology Corp. (TSX-V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.18, even for the day, on 43,960 volume. The stock's 52-week low/high is $0.1049/$1.20.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has successfully delivered nicotine in an edible form into blood plasma just minutes after dosing in an animal in vivo study. Lexaria's DehydraTECH(TM) technology delivered nicotine at each of the 2, 4, 6, 8 and 10-minute intervals post-dosing, with 90.2% greater delivery than the concentration-matched control formulation by the 10-minute mark (95% CI; p=0.044), and significantly greater absorption levels than the control formulation at all subsequent time points in the study. Also today, announces that it has issued a total of 355,000 restricted common shares as required by executive consulting agreements, shared by the Chief Executive Officer and the President of the Company.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.76, up 3.83%, on 185,625 volume with 282 trades. The average volume for the last 60 days is 234,817 and the stock's 52-week low/high is $0.322/$2.54.

Recent News

chart

Cannabis Strategic Ventures, Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures (OTC: NUGS) is engaged in supporting entrepreneurial growth within the burgeoning legal cannabis market. To view the full article, visit: http://cnw.fm/BHf6L.

Cannabis Strategic Ventures, Inc. (OTC: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $2.10, up 3.96%, on 6,682 volume with 27 trades. The average volume for the last 60 days is 34,495 and the stock's 52-week low/high is $0.031/$7.13.

Recent News

chart

NUGL Inc. (OTC: NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry's new standard of technology, today announces its North American Marketing Strategy. NUGL’s revolutionary platform delivers exclusive profiles and features for brands and listings in the cannabis space. NUGL’s industry-leading search app offers every type of cannabis company and professional service the ability to create individual profiles for marketing, connecting and expanding client bases in and out of the NUGL community. NUGL’s platform also gives brands and listings cutting edge software that helps their business expand their client base and network.  

NUGL Inc. (OTC: NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.39, up 0.72%, on 109,673 volume with 100 trades. The average volume for the last 60 days is 122,501 and the stock's 52-week low/high is $0.405/$1.80.

Recent News

chart

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42)

The QualityStocks Daily Newsletter would like to spotlight FANDOM SPORTS Media Corp. (FDMSF).

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) (“FANDOM SPORTS” or the “Company”), creator of FANDOM SPORTS, the new app that aggregates, curates and produces fan-focused content, is today pleased to provide an overview and management summary of the last two quarters. Also today, NetworkNewsWire released a report on the company covering FDMSF’s issuance of an overview and management summary for the last two quarters.

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) is a sports entertainment and gaming company “Hell Bent” on finding and creating the best sports content. FANDOM SPORTS allows passionate fans to unleash their primal sports passions by engaging with other fans, cheering for their favorite teams, players and jeering their opponents.

FANDOM SPORTS: The Brand

FANDOM SPORTS exists to allow sports fans to unleash their primal sports passions, to express their adoration for their teams and players, as well as their deep scorn for their opponents.

Building on the success of its current, 2015 designed, FANDOM Sports App, the company is phasing out systematically the legacy product and will launch an enhanced IBM Blockchain Platform accompanied by a new iOS and Android sports app in the fourth quarter of 2018. This core mobile product – the FANDOM SPORTS App – taps into the passion of sports fans around the world, bringing “trash talk” to a new level.

Currently in development with HHS Tech Group and overseen by IBM, the new platform will give FANDOM the flexibility to expand into new global markets by tailoring a shell app, based on demand, to that specific market. While the shell app will look and perform the same globally, it will produce new results depending on the user’s geographic location. For example, a FANDOM Sports App user in China may not be as interested in the NFL, NBA or NHL like a North American market. Instead, their interests could be in eSports and sports leagues native to their country.

With these features, the FANDOM SPORTS App is the ultimate destination for die-hard sports fans. The app enables users to follow their favorite live-action and fantasy teams and players, as well as test their sports knowledge and track viral sports highlights. During Online and live sporting events, professional athletes, commentators and users can engage and debate. It provides a place for fans to connect and square off in real-time with raw, authentic sports debates.

Users are able to log in, celebrate and commiserate with like-minded fans or debate the enemy. The FANDOM SPORTS app currently targets major sports, including football, basketball, baseball and hockey, with future global expansion based on demand and market expansion plans. FANDOM SPORTS’ mighty live sports metadata provider is the Sports radar.

The app’s FanFights feature allows sports fans to engage other users and unleash raw opinions, predictions and uncensored debates. Application-use is further driven when sports lovers can keep up with their favorite teams and players, trash talk, invite friends to “Pick a Fight” to win virtual currency and experience points status.

Business Strategy

FANDOM SPORTS has identified a relatively untapped sports market ripe with demand. Large-scale social media players are not nimble enough to fill this gap in the sports entertainment market, and this is where FANDOM SPORTS enters the game. As a newcomer to the market, the company has chosen best-in-class partners to make its platform and sports app.

Monetization is based on multiple potential revenue streams, including in-house advertising sales, brand partnerships, in-app purchases and more.

In addition to its one-of-a-kind, mobile-only IBM Cloud and IBM Blockchain platform, the company’s business model is based on unique features and gamification of FANDOM SPORTS to bring fans, athletes and celebrities together by blending user-generated and curated content.

Through its ability to engage users in a one-of-a-kind social media and competitive mobile sport experience, FANDOM SPORTS is well-positioned within the booming North American and international gaming markets, targeting sports super fans.

FANDOM SPORTS utilizes the IBM Watson learning algorithm, which predicts and services user preferences while building relevant personalized FANFIGHT channels. This brings sports entertainment to a new level, delivering competitive conversation and interaction that rival a sports bar into the user’s hand.

FANDOM SPORTS is led by a strategic management team with combined expertise and a great track record in business development, finance, technology and content curation. The team holds veteran expertise across entertainment, media and music industries, while the company’s advisory board boasts high-level executives, professional athletes and celebrities. New additions to the advisory board cover the massively growing arena of eSports.

Gamification

Functionality of the FANDOM SPORTS App enables users to engage in sports debates that have definite resolution from live games. The company is implementing strategies extensively used in the mobile gaming industry to attract its users in continued engagement with the FANDOM SPORTS App. Within the application environment, users become invested as “players” to build their profile (“Player Card”) while competing for rewards and prestige.

The app further engages players with a unique in-game virtual currency. Not intended for use in real-world gambling, the virtual currency holds in-app value. With the in-app currency, fans are able to create their own “FANFIGHTS,” “Pick a Fight,” and debate the outcome of arguments. Users are provided a fixed amount of app currency upon initial sign up. As the user contributes and engages with other fans, they accumulate more virtual currency FANCOIN, as well as a higher experience on the platform.

Within the application in Q4, users in certain regions can make in-app purchases to speed up their gaming experience, as well as “Pick A Fight” for prizes, in-game items and potentially live sporting events.

Market Opportunity

FANDOM Sports is establishing routes to take advantage of strong growth of mobile gaming and mobile games. The worldwide gaming market is forecast to rise to $137.9 billion in 2018, according to Newzoo.

Worldwide gaming is forecast to rise to US $144.31 billion by 2018. In 2015, the online gaming market had a volume of US $37.91 billion, and this figure was forecast to increase to US $59.79 billion in 2020. In 2015, the online gaming gross win accounted for 10 percent of the total gaming gross win, and this was forecast to increase to 14 percent in 2020.

Within this space, the FANDOM SPORTS App is the ultimate destination for die-hard sports fans to dive deeper. The app provides engaging and authentic real-time interactive content aimed right at the company’s targeted age demographic of 18-34. The FanFights on the app create a platform in which intense sports fans can engage other users, unleashing raw opinions, predictions and debates that you don’t want your mom to see on Facebook. Application use is further driven when sports lovers can keep up with their favourite teams and players, vent, gloat, invite friends to Pick A Fight and play to win virtual currency and experience points status.

Management

Henri Holm – Chief Executive Officer
Henri Holm is president and CEO of FANDOM SPORTS Media Corp. Holm has an extensive track record of business success, bringing over 20 years of international hands-on strategy execution experience. A Harvard Business School alumni, his career accomplishments include scaling-up functions of multinational firms and expertise in various leadership roles, including covering digital content and implementing as well as enhancing gamification, brand management, licensing, mobile technology, manufacturing, distribution and retail operations processes and functionality.

With key focus on consumer and partner value, Holm’s most recent executive position covered leading video products, billing and sports content services within the Middle-East region. Additionally, Holm was senior vice president at Rovio Entertainment, where he oversaw the development and growth of the highly successful Angry Birds franchise across Asia. Prior to these roles, Holm held progressive titles ranging from chief financial officer, head of Business Operations, Global Category Marketing Manager, key account manager and product manager at various divisions of Nokia from 1995 to 2011.

Jonna Birgans – President and Chief Content Officer
A 25-year veteran of the entertainment industry, Birgans has had an influential career across all entertainment mediums: television, film, radio and digital media. Birgans has worked extensively with global brands like Billboard Magazine, Viacom Networks and Lexus, producing content for their marketing campaigns as well as for their on-air shows. She has also had two development deals for TV shows she co-created at GSN and USA Networks. Birgans also has had a successful career as a music video producer, working alongside infamous directors Hype Williams and Spike Jonze, to name a few. For the last decade, Birgans has made a name for herself in the world of out-of-home and digital media landscapes performing in executive roles creating content strategy, developing business plans, executing brand partnerships and managing teams of creative and sales professionals.

Alex Helmel – Chief Financial Officer
Alex Helmel is CFO of FANDOM SPORTS Media Corp. He has extensive career experience with over 12 years in Canadian capital markets and over 20 years in the technology sector, focusing on asset development. Helmel has served in leadership positions for various successful companies including in roles as president, secretary and chief financial officer.

FANDOM SPORTS Media Corp. (FDMSF), closed the day's trading session at $0.0662, even for the day. The average volume for the last 60 days is 15,502 and the stock's 52-week low/high is $0.0601/$0.2864.

Recent News

chart

Sharing Services, Inc. (OTC: SHRV)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services, Inc. (SHRV).

Sharing Services Inc. (OTC Markets: SHRV) today announces the  selection of  Global Payroll Gateway (“GPG”) as its primary merchant processor and e-commerce financial partner. GPG will support and process sales of products and services for all of SHRV’s wholly owned subsidiaries including its flagship companies, “Elepreneur” and “Elevacity Global.”

Sharing Services, Inc. (OTC: SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services, Inc. (SHRV), closed the day's trading session at $0.28, even for the day, on 2,400 volume with 2 trades. The average volume for the last 60 days is 29,229 and the stock's 52-week low/high is $0.125/$1.07.

Recent News

chart

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF)

The QualityStocks Daily Newsletter would like to spotlight Pivot Pharmaceuticals Inc. (PVOTF).

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Definitive Agreement with Israeli-based SoluBest Ltd. to acquire the worldwide rights for the use, development and commercialization of its patented Solumer™ Oral Drug Delivery Technology ("Solumer™") for the improved bioavailability, delivery and commercialization of Cannabidiol (CBD), Tetrahydrocannabinol (THC) and other biocannabis-based products.

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.

Research into the bioavailability of cannabinoid-based therapeutics shows that rates of absorption vary greatly between smoking cannabis to an orally-consumed product, with a difference noted even between individuals. Cannabinoids are degraded in the stomach and smoking may not appeal to patients for health or lifestyle reasons. Topical delivery, while a better alternative, has suffered from weak formulation issues. Transdermal cannabinoid delivery, on the other hand, could provide a better alternative route since it reduces side effects and bypasses other absorption issues. In addition, transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects.

Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in FDA and EMA approved human clinical trials, which have shown the delivery system enhances the bioavailability of many drugs and improves clinical outcomes. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids (CBD) that can receive a Health Canada Natural Health Product (NHP) designation. This marketing method ensures a shorter development cycle and faster revenue generation opportunities.

Pivot Pharmaceuticals Inc., which has positioned itself as a growing and crucial vertical in the cannabis industry, represents a compelling opportunity in the biotechnology field. The company’s plans include working with Licensed Producers (LP) and Licensed Dealers (LD) to bring newer therapies to patients. The company has also applied to list on the Canadian Stock Exchange (CSE).

The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of states and countries gaining approval for using cannabis in therapeutic applications is expected to continue driving the market forward.

Pivot Pharmaceuticals has assembled a highly experienced management team, bringing together a wealth of clinical, commercial, product development and financial experience. Among the many healthcare targets in Pivot’s pipeline are cancer supportive care, pain and inflammation, women’s sexual dysfunction, dermatology and eye disease.

Pivot Pharmaceuticals Inc. (PVOTF), closed the day's trading session at $0.41235, off by 15.85%, on 74,833 volume with 48 trades. The average volume for the last 60 days is 105,281 and the stock's 52-week low/high is $0.047/$2.46.

Recent News

chart

WhereverTV Broadcasting Corp. (OTCQB: TVTV)

The QualityStocks Daily Newsletter would like to spotlight WhereverTV Broadcasting Corp. (TVTV).

NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with WhereverTV Broadcasting Corp. (OTCQB: TVTV), a client of NNW engaged in providing live-stream broadcast programming to consumers across multiple devices, geographies and languages. The interview can be heard at http://nnw.fm/g62YG.

WhereverTV Broadcasting Corp. (OTC: TVTV) is a next-generation OTT (Over-the-top) television subscription service that manages live-stream broadcast programming rights across multiple devices, geographies and languages, providing viewers with personalized service that is truly “wherever” they may be watching TV.

WhereverTV’s patented Interactive Program Guide (IPG) technology currently handles over 125 live channels that are broadcasted securely over the Internet to any Internet-enabled device anywhere in the world. Many of the company’s channels are the same as those broadcasted by traditional cable and satellite companies. For example, the World News Now package includes One America News, RT News (Russia Today), Bloomberg TV, CBN News and EuroNews Live — the latter provides pan-European coverage in 350 million households in 155 countries. Other channel packages include Choice TV (a wide variety of popular options for the family), Spanish TV, Faith TV and Morocco TV, providing current genre-specific subscriptions for news, faith, drama, sports, movie, reality and children’s programming.

WhereverTV’s free app works with iOS and Android devices to cover the spectrum of mobile consumer needs, as well as with personal desktop or laptop computers through its over the top (OTT) platform. The platform delivers channels, shows and events to SmartTVs and digital media receivers that include Google Chromecast, AppleTV, Amazon Fire TV, iPhone, iPad, Android Smartphone and TabletPCs, with DVR recording functionality slated for future development.

The company, based in Fort Myers, Florida, was developed in 2007 as a solution to its founder’s frustration with the complexities of trying to stream English speaking content while abroad. As the live-streaming market has developed over the decade since then, WhereverTV has gained recognition as a pioneer in next-generation content delivery systems.

WhereverTV’s strategy is to increase revenue-generating subscriptions worldwide through the acquisition of content that is desirable to consumers and deliverable anywhere a device can connect to the Internet. Prepaid accounts will be accessed through the cloud, and the IPG technology will allow users to make their viewing choices. The company has developed two separate divisions, one for worldwide distribution and one for Latin American distribution.

In 2017, the company acquired Digital Rodeo, LLC, a Tennessee limited liability company that delivers a rich mixture of music and videos from independent country artists, current arrests and legacy artists, as well as similar Florida-based companies Digital RodeoTV, LLC (Name changed to WhereverTV Country in 2018), Digital CrossTV, Inc., Digital PopTV, Inc., and Digital RockTV, Inc.

WhereverTV is transitioning from a development to operational company and in doing so we have refined our 2018 business model,” CEO Edward D. Ciofani stated. “Our business model calls for content acquisition from around the world, exclusive content development, Major Marketing Alliances, similar to the announced Google Chromecast for Latin America and major marketing initiatives including social media marketing. … There are a lot of content providers (channel providers) around the world that offer a uniquely diversified perspective of cultures, travel and lifestyle content.”

As an increasing number of people “Cord-Cutters” no longer subscribe to the traditional cable or satellite distribution but rather a simpler lower cost means of watching content. The streaming OTT industry is expected to grow to $62 billion by 2020 — nearly triple its revenues in 2015, per Goldman Small Cap Research. Future Market Insights estimated the North America OTT market alone at $16.29 billion in 2017 with a CAGR of 17.4 percent through 2028. The arrival of 5G technology this year has the potential to accelerate the pace.

WhereverTV Broadcasting Corp. (TVTV), closed the day's trading session at $0.0564, off by 19.31%, on 18,949 volume with 5 trades. The average volume for the last 60 days is 33,746 and the stock's 52-week low/high is $0.041/$0.46.

Recent News

chart

TMSR Holding Company (NASDAQ: TMSR)

The QualityStocks Daily Newsletter would like to spotlight TMSR Holding Company (TMSR).

TMSR Holding Company (NASDAQ: TMSR), together with its subsidiaries, is a recognized leader in the research, development, production and sale of solid waste recycling systems and zero emissions process systems, for the industrial and mining sectors in the People’s Republic of China. The company operates through its wholly owned business divisions: Shengrong Environmental and Wuhan HOST Coating Materials.

TMSR’s Shengrong subsidiary designs, builds, sells and services customized solid waste recycling systems and equipment for some of the largest industries in China. The company provides customers full-service, tailor-made systems from conceptual design to planning, production, modernization, optimization, assembly, start-up, conversions, disassembly, maintenance and servicing of components to complete zero emissions solid waste recycling and process systems.

Utilizing what management believed to be the world’s most advanced technologies of physical magnetic industrial solid waste recovery, Shengrong can process a variety of industrial solid waste materials and is able to extract valuable metal byproducts from the waste without generating any chemical pollution. Shengrong’s patented equipment can process aluminum slag, copper mine tailings, iron mine tailings, red mud manganese tailings, and molybdenum tailings among many others. Unlike traditional chemical-based recovery methods, the company extracts resalable metals from the waste without generating any pollution. The residues are processed to manufacture high-quality construction materials, turning polluted solid waste into valuable industrial materials with zero discharge.

Industrial solid waste recycling and heavy metal removal are significant worldwide technical, financial and environmental issues. Through Shengrong, TMSR is addressing this profound unmet market need by delivering end users a clean alternative to traditional waste disposal. The company intends to leverage these serious unmet needs, expand its patented industrial waste recycling systems to broad international markets, and provide global industrial and mining businesses cost-effective, patented green technology platforms that create new-found revenue streams for end users.

Through Shengrong, TMSR owns two U.S. patents and five patents granted by the Peoples Republic of China, including four invention patents and two utility model patents. The company’s research and development efforts have achieved technological advancements that allow end users to eliminate pollutant discharge as well as generate new revenue streams by selling valuable byproducts extracted from industrial waste.

TMSR subsidiary, Wuhan HOST Coating Materials, is the largest manufacturer of inorganic Zinc-rich resin and one-component epoxy Zinc-rich resin in China. Established in 2010, Wuhan HOST is a leader in the research and development, production and sale of Zinc-rich coating materials throughout the PRC and has a broad customer base that includes some of the foremost enterprises in major industries such as electricity, metallurgy, machinery, chemicals, bridge and shipping. TMSR completed the acquisition of 100% equity interest in Wuhan HOST Coating Materials on May 1, 2018.

Notably, TMSR first went public as JM Global Holding Company, a Special Purpose Acquisition Company (SPAC) formed to effect a merger, asset acquisition or other business combination that had exceptional growth potential. After reviewing over 50 potential targets and completing due diligence and third party analysis, JM Global identified China Sunlong Environmental Technology Inc. and its wholly owned subsidiaries as the acquisition target. Upon closing the business combination, the company was re-named TMSR Holding Company Ltd.

Demand for TMSR’s products is expected to grow significantly due to Chinese policies that encourage mining and manufacturing companies to adopt “green” technology. Approximately 3 billion tons of industrial solid waste were generated annually in China between 2011 through 2015.  Currently, 95% of industrial solid waste in China is stored in special facilities and sites; however, the cost of storage, disposal and incineration of industrial solid wastes is high. TMSR is focused on exploiting this unmet need, providing end users in the solid waste recycling markets a clean alternative to traditional waste disposal, significantly reducing solid waste discharge into the environment and enabling end users to extract value from industrial waste materials.

TMSR Holding Company (TMSR), closed the day's trading session at $4.175, up 9.87%, on 751 volume with 4 trades. The average volume for the last 60 days is 1,044 and the stock's 52-week low/high is $3.50/$6.37.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.